Intervention

Furosemide

ClinicalTrials.gov intervention label

Clinical trials47
Recruiting2
Common conditions25
Lead sponsors shown15

Clinical trials

47 shown
Contrast-Induced Acute Kidney Injury Prevention in Acute Heart FailureNCT07550790 · 2026-07-01
RECRUITING
Diuretics vs. Afterload Reduction for Treatment of HeartLogic AlertsNCT06218199 · 2021-07-08
RECRUITING
ACetazolamide in Patients With Heart Failure, to Decrease Weight and relIEVE Symptoms.NCT07737964 · 2026-10-01
NOT_YET_RECRUITING
Furosemide vs Placebo in Severe Preeclampsia PostpartumNCT07648251 · 2026-06-15
NOT_YET_RECRUITING
SURE-HF: Urinary Sodium-Guided Diuretic Therapy in Heart FailureNCT07631780 · 2026-06-01
NOT_YET_RECRUITING
A Study of Ultra High Dose Diuretics to Treat Heart FailureNCT06036914 · 2023-11-27
COMPLETED
Diuretic Strategies in Acute Heart Failure Patients at High Risk for Diuretic ResistanceNCT05986773 · 2023-10-10
TERMINATED
A Study to Compare How Different Medicines (Rosuvastatin, Digoxin, Metformin, and Furosemide) Are Handled by the Body of Healthy People and People With Liver CirrhosisNCT05741372 · 2023-09-07
COMPLETED
Comparison of 18F-rhPSMA-7.3 PET/CT With and Without Furosemide in Biochemical Recurrence of Prostate CancerNCT05779943 · 2023-04-27
ACTIVE_NOT_RECRUITING
The Addition of Inhaled Furosemide to Standard Treatment of COPD ExacerbationNCT05769738 · 2023-03-01
UNKNOWN
Lasix for the Prevention of De Novo Postpartum HypertensionNCT04752475 · 2021-10-20
COMPLETED
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Drug Effects of BMS-986308 in Healthy ParticipantsNCT04763226 · 2021-04-14
COMPLETED
Efficacy and Safety Evaluation of Tolvaptan in the Treatment of Patients With RHF Caused by PAHNCT05569655 · 2021-04-06
UNKNOWN
Torsemide Comparison With Furosemide for Management of Patients With Stable Heart FailureNCT05093621 · 2021-02-08
COMPLETED
Furosemide vs. Placebo for Severe Antepartum HypertensionNCT04615624 · 2021-01-04
COMPLETED
A Trial to Study BAY1753011 in Patients With Congestive Heart FailureNCT03901729 · 2019-05-29
COMPLETED
Protocol of Diuretics Use in Congestive Therapy in Heart FailureNCT03892148 · 2019-05-17
COMPLETED
An Investigational Study of Continuous 8-Hour Intravenous Administrations of BMS-986231 in Participants With Heart Failure and Reduced Heart Function Given a Standard Dose of Loop DiureticNCT03730961 · 2019-01-17
COMPLETED
TRANSFORM-HF: ToRsemide compArisoN With furoSemide FORManagement of Heart FailureNCT03296813 · 2018-07-11
COMPLETED
Pharmacokinetics, Safety and Tolerability of Concurrent Doses of BIA 5-1058 and FurosemideNCT07173738 · 2018-06-11
COMPLETED
Intravenous Vasodilator vs. Inotropic Therapy in Patients With Heart FailureNCT02767024 · 2018-05-01
WITHDRAWN
Effects of Furosemide Plus Small HSS in Subjects With Heart Failure With Reduced Ejection Fraction (HFrEF)NCT04628325 · 2017-03-01
COMPLETED
A Trial Investigating the Effect of Oral Semaglutide on the Pharmacokinetics of Furosemide and Rosuvastatin in Healthy SubjectsNCT03010475 · 2017-01-05
COMPLETED
Short-term Efficacy of Furosemide, Isosorbide Dinitrate and Their Combination in ADHFNCT02649998 · 2017-01-01
WITHDRAWN
Subcutaneous Furosemide in Acute Decompensated Heart Failure PilotNCT02877095 · 2016-12-19
COMPLETED
Prevention of Severe Postpartum HypertensionNCT02450773 · 2015-08-01
WITHDRAWN
Effect of Furosemide Withdraw in Stable Chronic Heart Failure OutpatientsNCT02689180 · 2015-05-01
UNKNOWN
Aquaresis Utility for Hyponatremic Acute Heart Failure StudyNCT02183792 · 2014-12-01
COMPLETED
Aerosol Inhalation Treatment for Dyspnea - PatientsNCT02524054 · 2014-11-01
COMPLETED
A Study of MK-7145 in Participants With Renal Insufficiency (Part I) and Heart Failure With Renal Insufficiency (Part II) (MK-7145-011)NCT01558674 · 2014-05-23
TERMINATED
Combination Diuretic Therapy for Acute Decompensated Heart FailureNCT05840536 · 2014-05-01
WITHDRAWN
A Prospective, Single-center, Randomized, Controlled, Open-label, Pilot Study to Compare the Effectiveness and Safety of DIuretics Add-On Strategy in Acute Decompensated Heart Failure Patients (DIOS II)NCT02047422 · 2014-01-01
WITHDRAWN
The Impact of TORasemide oN hemodynAmic and Neurohormonal Stress, and carDiac remOdeling in Heart FailureNCT01942109 · 2013-09-01
UNKNOWN
Diuretics and Dopamine in Heart Failure With Preserved Ejection FractionNCT01901809 · 2013-08-01
COMPLETED
Effectiveness of a Diuretic Algorithm in Clinical Stability in Heart Failure PatientsNCT02068937 · 2013-05-01
COMPLETED
Ultrafiltration (Aquapheresis) in Patients With Leukemia and Severe Fluid OverloadNCT01508260 · 2013-03-01
WITHDRAWN
OUTpatient Intravenous LASix Trial in Reducing Hospitalization for Acute Decompensated Heart FailureNCT04691687 · 2012-05-01
COMPLETED
Troponin I Release After High Diuretic DosesNCT01419132 · 2011-08-01
COMPLETED
Bumetanide Versus Furosemide in Heart FailureNCT00372762 · 2011-01-01
WITHDRAWN
Effect of Furosemide on Obesity-induced Glomerular HyperfiltrationNCT00962286 · 2009-09-01
TERMINATED
The Effects of Decreasing the Lasix Dose on the Cardiorenal SystemNCT00982423 · 2009-07-01
COMPLETED
Comparing the Effects of Conivaptan and Diuretics on Plasma Neurohormones and Renal Blood Flow in Patients With Chronic Congestive Heart FailureNCT00924014 · 2009-07-01
UNKNOWN
Dopamine in Acute Decompensated Heart Failure (DAD-HF) TrialNCT00937092 · 2009-01-01
UNKNOWN
A Study To Compare Effects Of GSK189075 In Combination With Either Furosemide Or HydrochlorothiazideNCT00671424 · 2008-03-01
COMPLETED
Effect of a New Formulation of Torasemide (Prolonged Release)on Myocardial Fibrosis in Patients With Heart Failure.NCT00409942 · 2007-03-01
COMPLETED
Loop Diuretics in Chronic Kidney DiseaseNCT00478543 · 2005-09-01
COMPLETED
Hypertension Screening and Treatment ProgramNCT00007592 · 1989-06-01
COMPLETED

Common conditions

Trial status mix

COMPLETED25
WITHDRAWN7
UNKNOWN6
NOT_YET_RECRUITING3
TERMINATED3
RECRUITING2
ACTIVE_NOT_RECRUITING1

Phase mix

PHASE413
NA10
PHASE39
PHASE18
PHASE28

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.